The thing is ISIS has moved on a number of developments within their own pipeline aside from ANP having several anti-sense candidates the rise is really not neccessarily relevant to ANP...
ISIS rise of 30% since the beginning of December with multiple developments to validate the rise -
> $30M cash payment from Biogen
> 3 new drugs added to development pipeline
> positive data from 3 phaseI trials
> 2 new drugs commence phaseI trials
isis gathering momentum, page-67
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.015(13.0%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 12.0¢ | $612.7K | 4.843M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56662 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 600000 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |